Baltimore, MD, United States – BD Diagnostics, and Lonza Group Ltd announced today that they have entered into an exclusive licensing and collaboration agreement for Lonza to commercialize its microCompass™ molecular assays. BD Diagnostics, a segment of BD (Becton, Dickinson and Company), and Lonza Group Ltd announced today that they have entered into an exclusive […]

The two companies will co-market assay kits optimized for the Gyros immunoassay platform Uppsala, Sweden: Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today that the company has entered into a global collaboration agreement with Cygnus Technologies Inc., focused on the development of assay kits optimized for the […]

BEVERLY, Mass. – Sage Science, Inc. (a privately-held, MA-based company) today announced that it has signed a co-marketing agreement with Illumina, Inc. (NASDAQ:ILMN). Illumina and Sage have agreed to co-market the Pippin Prep system in an effort to provide automated gel technology for library size selection to Illumina sequencing customers. The Pippin Prep automates size […]

Incorporation of analytical and preparative microfluidics solutions improves data quality and simplifies next generation sequencing sample preparation HOPKINTON, Mass. – Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced a co-marketing agreement with Illumina, Inc. (Nasdaq: ILMN) for Caliper’s LabChip® XT library preparation instrument and its LabChip GX analytical quality control platform. These systems are automated […]

NOVATO, CA – Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has licensed access to the BHQ®, CAL Fluor® and Quasar® patents to Seegene (KOSDAQ; Korea Securities Dealers Automated Quotations). In addition, Biosearch will manufacture both research and IVD grade […]

Paraytec (York, UK) proudly announce Distek, Inc., an industry leader in dissolution testing products and validation services, to be a U.S. distributor of the ActiPix™ SDI300. The ActiPix™ SDI300 is a technological breakthrough in surface dissolution imaging. The ActiPix™ SDI300 provides unique insights and understanding into the processes taking place at the liquid/surface interface. It […]

First patent license in the therapeutic field Paris (France) and Kyoto (Japan) – Cellectis (Alternext: ALCLS), the French genome engineering specialist, and iPS Academia Japan Inc. (Kyoto, Japan) announced today that they have signed two separate non-exclusive agreements granting Cellectis worldwide access to the induced Pluripotent Stem (iPS) cells patent portfolio arising from the work […]

San Diego, CA and Ottawa, Canada – Fate Therapeutics, Inc. has forged a collaboration and license agreement with BD (Becton, Dickinson and Company), a leading global medical technology company, through its BD Biosciences segment, for the joint development and worldwide commercialization of induced pluripotent stem cell (iPSC) tools and technologies for drug discovery and development. […]

Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, announced today a strategic partnership with Mustard Tree Instruments, Inc. Pharmaceutical, chemical and healthcare product industries are seeking more efficient methods for ensuring quality and consistency in manufacturing. This collaboration will allow Mustard Tree to accelerate advances in the […]